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Abstract
Aim of study: To examine the influence of administering cyproterone acetate (CPA), at the beginning of the mating season, on the testos-
terone concentration and morphometric and functional characteristics of ram and buck semen.
Area of study: Madrid, Spain
Material and methods: Five rams and five bucks were intramuscularly administered 200 mg of CPA in 2 mL of olive oil twice per week - 
from July 1st to 31st in the rams, and from August 1st to 31st in the bucks. Five control animals of each species were administered 2 mL of 
olive oil. Blood samples and ejaculates analysed from the start of treatment until eight weeks after the last day of treatment.
Main Results: GLM-ANOVA showed the interaction species × CPA treatment to have effect (p<0.05) on sperm motility, progressive 
motility and acrosome integrity; and greater effect (p<0.01) on curvilinear velocity (VCL), straight-line velocity (VSL), viability, and mor-
phological abnormalities. In both the rams and bucks, plasma testosterone levels fell from the first week from the start of CPA administration 
until three weeks after the end of treatment. In rams, the total sperm count, sperm motility, progressive motility, viability, morphological 
abnormalities, VCL and VSL were all negatively affected by the treatment (p<0.001); acrosome integrity was also affected (p<0.05). In 
bucks, sperm motility, progressive motility, VCL, VSL and morphological abnormalities were negatively affected (p<0.05).
Research highlights: Treatment with CPA affected testosterone secretion, semen characteristics and sperm morphometry in both the rams 
and bucks, and thus it might be used as short term contraceptive protocol in small ruminants.
Additional key words: livestock; male reproduction; ruminants; sperm; testicular activity.
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Introduction
Cyproterone acetate (CPA) [6-chloro-17α-hy-
droxy-1,2α-methylene-Δ 4,6-diene-3,20-dione-acetate] 
is the only pharmaco-hormonal compound with anti-an-
drogenic, anti-gonadotropic and progestational properties 
(Neumann & Berswordt-Wallrabe, 1966; Steinbeck et al., 
1971). In males it behaves as an anti-androgenic steroid, 
acting (i) as a competitive antagonist of androgen recep-
tors, thereby inhibiting testosterone and 5-α-dihydrotes-
tosterone synthesis (Semet et al., 2017), (ii) as an anti-go-
nadotropic agent that reduces the secretion of luteinizing 
hormone (LH) and follicle stimulating hormone (FSH), 
thus suppressing the secretion of androgens (Balbontin & 
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Ferrario, 1993; Meriggiola et al., 2003) and (iii) its pro-
gestational action confers additive and synergistic effects 
on the ability to suppress gonadotropin levels (Balbontin 
& Ferrario, 1993; Meriggiola et al., 2003).
The first reports on the functional effects of CPA indi-
cated it to very significantly reduce the fertility of male 
rats (Whalen & Luttge, 1969); subsequent studies con-
firmed its impact on reproductive function via the inhi-
bition of spermatogenesis, the perturbation of sperm cell 
maturation in the epididymis, and by its impairment of 
the functioning of the accessory sex glands, resulting in 
a loss of sperm motility and reduced viability (Prasad et 
al., 1970).
The antiandrogenic properties of CPA have been wi-
dely used in urological clinic for treatment of advanced 
human prostate cancer (Guo et al., 2017) or suppression 
of sexual disorders (Neumann, 1994). In addition, rever-
sible inhibition of testosterone secretion by the action of 
CPA (Meriggiola et al., 2003) has allowed its use as a 
hormonal contraceptive in men; CPA induces a marked 
reduction in sperm concentration and motility, plus a mo-
derate reduction in the volume of seminal fluid and testi-
cular germ cell numbers (Morse et al., 1973; Koch et al., 
1976). Despite that a hormonal regimen consisting of tes-
tosterone plus CPA holds promise as an effective, safe and 
reversible male contraceptive (Meriggiola et al., 1998), 
questions remain regarding the time required to reach 
their full contraceptive effect, and the time that elapses 
between cessation of hormonal contraceptive treatments 
and full spermatogenesis recovery in men (Khourdaji 
et al., 2018).
As an androgen inhibitor, CPA has been used in ani-
mals for assessing the role of testosterone on antler grow-
th and shedding in fallow deer (Bartoš et al., 2000), red 
deer (Jaczewski et al., 2004), and white-tailed deer (Bu-
benik et al., 1987). It has been used in a similar fashion to 
investigate the role of testosterone on seasonal changes in 
horn growth in wild Iberian ibexes (Santiago-Moreno et 
al., 2012), and endocrine relationships between rank rela-
ted behavior and growth of antlers in deer (Bartoš, 2012). 
Notwithstanding its strong anti-androgen properties, the 
literature contains no studies on the use of CPA as an ani-
mal contraceptive in non-primates species (Barfield et al., 
2006). Effective contraceptive treatments are needed for 
temporary contraception in wildlife species, and even do-
mestic species, maintained in zoos, wildlife sanctuaries 
and smaller conservancies where populations need to be 
controlled, indiscriminate reproduction in mixed herds 
needs to be avoided, and unwanted aggression needs to be 
attenuated (Barfield et al., 2006).
Small ruminants native from temperate latitudes show 
a strong seasonality in their reproductive activity with 
highest testosterone concentration occurring for a few 
months throughout the year (Santiago-Moreno et al., 
2005; Gómez-Brunet et al., 2012). A potential use of CPA 
as contraceptive agent in these species may be expected 
since early studies showing inhibition of sexual behavior 
(Fabre-Nys & Signoret, 1980) and a harmful effect on epi-
didymal sperm motility and morphology (Panda & Jindal, 
1982) after CPA administration. 
Therefore, the aims of the present study were to exa-
mine the effects of CPA on semen characteristics in both 
rams and bucks, and to determine the time that elapses be-
tween cessation of contraceptive treatment and the reco-
very of physiological testosterone secretion. For this pur-
pose we used a short-term protocol of CPA administration 
during four weeks (Santiago-Moreno et al., 2012). Taking 
into account the short annual period with high levels of 
testosterone, and that functional recovery period of testes 
after CPA interruption appears to be directly proportio-
nal to the duration of treatment in rodents (Rastogi et al., 
1980), the CPA was administered at the onset of the re-
productive season. These results can yield particularly in-
teresting results for reversible contraception in both wild 
and domestic ruminants. 
Material and methods
All the experimental procedures reported here were 
approved by the INIA Ethics Committee and carried out 
in accordance with Spanish Animal Protection Policy (RD 
53/2013), which complies with EU Directive 2010/63/EU 
regarding the protection of animals used in scientific ex-
periments.
Cyproterone acetate for administration
CPA (Androcur, Schering A.G., Berlin, Germany) for 
administration was prepared by dissolving 3.2 g of this 
compound in 7 mL of benzyl benzoate and then adding 
25 mL of olive oil, obtaining a final CPA concentration of 
100 mg/mL. This mixture was prepared with agitation at 
120ºC for 10 min (Santiago-Moreno et al., 2012).
Experimental animals
The study animals were 10 Spanish Merino rams and 
10 Murciano-Granadina bucks (all 3 years old), housed 
in adjacent 250 m2 enclosures under natural daylength 
and temperature conditions at the Department of Ani-
mal Reproduction of the INIA in Madrid (latitude, 40° 
25 'N). All animals were fed a balanced diet Visan K59 
(Visan Ind. Zoot., Madrid, Spain), which is based on 
barley grain, barley straw and dry alfalfa. They had free 
access to water and vitamin/mineral blocks and received 
routine veterinary treatment for the control of internal 
parasites.
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Experimental procedures
Treatments coincided with maximum testosterone se-
cretion defined for each breed in our latitude, according 
with previous studies in our lab (Santiago-Moreno et al., 
2005; Gómez-Brunet at al., 2012). Five rams and five 
bucks were intramuscularly administered 200 mg CPA in 
2 mL of olive oil (100 mg/mL) twice per week (Mon-
day and Friday), from July 1st-31st (approx. weeks 1-4) 
for the rams, and from August 1st-31st (approx. weeks 
1-4) for the bucks, dates corresponding to the period of 
increased testosterone secretion during these species an-
nual reproductive cycle (Santiago-Moreno et al., 2005; 
Gómez-Brunet at al., 2012). This administration proto-
col helps reduce testosterone in blood plasma to basal 
(non-reproductive period) concentrations (Santiago-Mo-
reno et al., 2012). Five male control animals of each spe-
cies were intramuscularly administered 2 mL olive oil wi-
thout CPA twice per week (Monday and Friday) over the 
corresponding periods. Sample collection and analyses 
were performed as described below.
  
Collection of blood and semen samples, and 
measurement of scrotal circumference
The entire experimental period lasted 13 weeks. Over 
the CPA administration period (approx. weeks 1- 4), and 
over the following 9 weeks (i.e., until week 13) blood 
samples were taken from each animal every Wednesday 
by jugular venipuncture; samples were collected in 5 mL 
plastic serum tubes (BD Vacutainer®, Becton Dickinson 
Co., Plymouth, UK). At the same time, the circumference 
of the scrotum was recorded at the point of the widest dia-
meter using an orchidometer (Ideal Instruments, Neogen 
Corporation, Schiller Park, IL, USA). Six ejaculates were 
also obtained from each animal using an artificial vagi-
na (Cassou IMV Technologies, L'Aigle, France); an oes-
trus induced ewe was used as a teaser to stimulate sexual 
behaviour. Samples were collected in 15 mL centrifuge 
tubes (Sterilin®, Stone, UK). These six samples inclu-
ded one before the start of CPA treatment (week 0), one 
during treatment (week 2), and four after the last day of 
treatment, with an interval of 15 days between collections 
(weeks 5, 8, 10 and 13). All semen samples were transpor-
ted to the laboratory at 37°C and assessed (all within 30 
min of collection).
Blood and seminal plasma testosterone assays
Blood samples were centrifuged at 1500 g for 15 min. 
Aliquots of the semen samples were left for 3 h at room 
temperature (18-24°C) and then centrifuged at 2400 g 
for 10 min. In both cases, the supernatant was removed 
and stored at -20°C for later analysis. Blood plasma and 
seminal plasma concentrations were measured by ra-
dioimmunoassay in duplicate aliquots (100 μL) as pre-
viously described (Santiago-Moreno et al., 2005). All 
samples were analyzed in a single assay. The sensitivity 
was 0.05 ng/mL. The intra-assay coefficient of variation 
was 10.3% (n=10) for the blood plasma analysis, and 11% 
(n=7) for the seminal plasma analysis.
Semen characteristics assessment
The volume of ejaculates was measured using a micro-
pipette (Gilson, Villiers Le Bel, France). Fractions of the 
samples destined for assessment were diluted 1:1 (v/v) in 
TCG solution (313.7 mM Tris, 104.7 mM citric acid, 30.3 
mM glucose, 345 mOsm/kg, pH 6.8) for the bucks, and 
TTG solution (210.6 mM Tes, 95.8 mM Tris, 10.1 mM 
glucose, 320 mOsm/kg, pH 6.8-7.2) for the rams. 
Sperm concentration (×106/mL) was measured in un-
diluted semen samples using a photometer (SMD1®, 
Minitube, Tiefenbach, Germany). Sperm motility was 
determined using a computer-assisted analysis system 
(CASA) coupled to a model 50i Nikon Eclipse nega-
tive phase contrast microscope and using Sperm Class 
Analyzer (SCA®) v.4.0 software (Microptic S.L., Barce-
lona, Spain). Samples were diluted 1:200 (v/v) in TTG or 
TCG medium according to the species, loaded into a 20 
μm Leja® chamber (Leja Products B.V., Nieuw-Vennep, 
The Netherlands) and assessments made at 37°C. We re-
corded the percentage of motile sperm, and that of sper-
ms showing progressive motility, the curvilinear velocity 
(VCL; μm/s) and straight-line velocity (VSL; μm/s). All 
analyses involved the capture of three fields and the exa-
mination of 500 sperm tracks at a magnification of 100x 
(image acquisition rate 25 frames/s).
Acrosome integrity and sperm viability were deter-
mined by fluorescence microscopy, analyzing 200 sperm 
cells, using propidium iodide (PI, Sigma P-4170) and 
fluorescein isothiocyanate-conjugated peanut agglutinin 
(PNA-FITC; Sigma L7381) fluorescent probes (Soler et 
al., 2005). Samples were examined using a Nikon Eclipse 
E200 epifluorescence microscope (excitation 450-490 nm, 
emission: 520 nm) (Nikon Instruments Inc, NY, USA).
Morphological abnormalities were assessed by phase 
contrast microscopy (×400) in samples previously fixed 
in a solution of 2% glutaraldehyde in BL-1. Two hundred 
sperm cells were examined, and eight sperm types clas-
sified: normal, decapitated, macro/microcephaly, broken 
neck, defective intermediate piece or double tract, coiled 
or broken tail, and cytoplasmic drop (Frank, 1950). 
Morphometric analyses of sperm heads were perfor-
med using samples collected at weeks 0, 8 and 13, em-
ploying a model 50i Nikon Eclipse microscope (Nikon 
Corporation, Tokyo, Japan) with a clear field objective at 
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60×, and making use of Sperm-Class Analyzer softwa-
re v.5.3.0.1 (morphometry module) (SCA®, Microptic 
SL Barcelona, Spain). A total of 100 spermatozoa were 
analyzed per sample after fixing and staining with He-
macolor®. The width (μm), length (μm), area (μm2) and 
perimeter (μm) of the sperm heads were determined as 
previously described (Esteso et al., 2015).  
Statistical analysis
Statistical analyses were performed using STATISTI-
CA software for Windows v.12 SP3 (StatSoft, Tulsa, OK, 
USA). Variables with skewed distributions, as determi-
ned by the Shapiro-Wilk test for normality (p<0.05), 
were either arcsine-transformed (for sperm motility, 
progressive motility, viability, acrosomal integrity and 
morphological abnormalities) or log-transformed (for 
blood testosterone levels, total sperm, VCL, VSL and 
morphometric variables [i.e., non-percentage values]) 
before analysis. The effect of the interaction species × 
cyproterone treatment on testosterone concentrations 
and semen characteristics were assessed using general 
linear model (GLM) repeated measures ANOVA. In the 
model, the species (buck-ram) and treatment (oil-CPA) 
were included as categorical predictor variables, and 
weeks (1-13) as within-subject factors (repeated me-
asures). The influence of the treatment in each species 
on the testosterone concentration and semen characte-
ristics was assessed by repeated measures ANOVA and 
the post-hoc Tukey test for multiple comparisons. Wee-
kly comparisons between treatment groups and controls 
were performed using the Student t-test for independent 
samples. Data were expressed as means±SEM, with the 




GLM repeated measures ANOVA showed the interac-
tion species × CPA treatment to have no significant effect 
on testosterone concentrations. 
In the rams, the blood plasma testosterone level was 
affected quickly and strongly by CPA treatment (p<0.01), 
with differences detected compared to the controls 
throughout the experimental period (p<0.05) (Fig. 1A). 
Indeed, they were close to the limit of detection during 
weeks 1 to 7. The first recovery in the testosterone con-
centration occurred at week 8 (4 weeks after the end of 
CPA administration). Testosterone levels became fully 
restored at week 11-12 of the study (7-8 weeks after the 
end of CPA administration). 
In the bucks, blood plasma testosterone was also affec-
ted by CPA treatment compared to the controls, with re-
ductions (p<0.001) detected throughout the experimental 
period. Testosterone levels reached their minimum values 
between weeks 2 and 7. The first recovery occurred at 
week 8-9 (i.e., 4-5 weeks after the end of CPA adminis-
tration) (Fig. 1B).
Scrotal circumference 
GLM repeated measures ANOVA showed the interac-
tion species × CPA treatment to have effect (p<0.01) on 
scrotal circumference. In the rams, reductions (p<0.001) 
were seen in scrotal circumference at weeks 5 (33.30 
± 1.39 cm vs 27.55 ± 0.42 cm), 8 (33.17 ± 2.03 cm 
vs 23.25 ± 0.48 cm), 10 (31.00 ± 1.63 cm vs 22.60 ± 
0.41 cm) and 13 (36.80 ± 1.86 cm vs 27.53 ± 0.14 cm) 
compared to the controls (with differences detected in 
the treated animals throughout the experimental period 
(p<0.05)). In the bucks, treatment also reduced the scro-
tal circumference compared to the controls at weeks 
5 (26.28 ± 1.27 vs 23.32 ± 0.40) and 8 (27.03 ± 1.49 
vs 22.68 ± 0.75) (again with significant differences in 
the treated animals throughout the experimental period 
(p<0.05)). 
Semen characteristics
GLM repeated measures ANOVA showed the interac-
tion species × CPA treatment to have effect (p<0.05) on 
sperm motility, progressive motility and acrosome inte-
grity. A greater effect (p<0.01) was found on VCL, VSL, 
viability, and morphological abnormalities.
In the rams, CPA treatment led to poorer values for 
the total sperm count, sperm motility, progressive moti-
lity, viability, morphological abnormalities and the VCL 
and VSL compared to controls (all p<0.001) from week 
2 (normal values were not fully re-established even by 
week 13) (Fig. 2). Acrosome integrity was also negatively 
affected (p<0.05). Again, differences were detected in the 
treated animals for all semen characteristics throughout 
the experimental period (p<0.05). The treatment affected 
to a greater extent at week 8 where four males presented 
azoospermia.
In the bucks, sperm motility, progressive motility, 
morphological abnormalities (all p<0.05), VCL and VSL 
(p<0.01) were all negatively affected compared to con-
trols (between weeks 2, 5 and 10 for the first two varia-
bles, and weeks 2 and 5 for the third) (Fig. 3). Once again, 
differences throughout the experimental period were de-
tected within the treated group for all semen characteris-
tics (p<0.05). Between weeks 2 and 5, four of the five 
males presented azoospermia.
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Sperm head morphometry
GLM repeated measures ANOVA showed the interac-
tion species × CPA treatment to have effect (p<0.05) on 
length, perimeter and area of the sperm head. In the rams, 
the CPA treatment reduced sperm length, area and peri-
meter from the weeks 8 and 13 of the study period com-
pared to week 0 (p<0.05). However, no significant diffe-
rences were seen between the treated and control groups 
at any time (Table 1). In the bucks, CPA treatment did not 
significantly affect any morphometric variable at any time 
(Table 1).
Discussion
The present results show that, in rams and bucks, treat-
ment with 400 mg/week i.m. CPA for 4 weeks reduces 
plasma testosterone levels from the first week after the 
first dose, to 3 weeks after the end treatment. It also re-
duces scrotal circumference, semen volume and semen 
characteristics, and affects sperm morphometry. This re-
duction in plasma testosterone is explained by the anti-an-
drogenic and anti-gonadotropic actions of CPA (Wiechert 
et al., 1966; Neumann & Töpert, 1986). The rapid reduc-
tion in blood plasma testosterone levels in both species 
is similar to that observed in white-tailed deer (Bubenik 
et al., 1987), fallow deer (Kolle et al., 1993) and the Ibe-
rian ibex (Santiago-Moreno et al., 2012). After the end 
of CPA treatment, blood plasma testosterone levels in the 
rams remained at basal levels for 3 weeks; they returned 
to approximately pre-treatment levels about 8 weeks after 
the end of treatment. In the bucks, plasma testosterone 
concentrations were restored by 5 weeks after the end of 
treatment. This re-normalization time reflects that requi-
red for the complete recovery of androgen synthesis by 
the Leydig cells. For both species, this period is much 
shorter than the 6-12 months required in humans after 
Figure 1. Weekly changes in plasma testosterone concentrations in 
blood (ng / mL) of Spanish Merino rams (A) and Murciano-grana-
dina bucks (B) (mean ± SEM) in the control (○) and treatment (●) 
groups during the experimental period. Asterisks indicate a significant 
decrease (*p<0.05) in the treated group. CPA: Cyproterone acetate.
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treatment with GnRH agonists (Nejat et al., 2000; Shahidi 
et al., 2001; Kaku et al., 2006). The protocol used in the 
present study is thus effective in achieving testosterone 
deprivation for a short time. 
The present CPA treatment also induced a significant 
reduction in scrotal circumference in both species, as re-
ported in other studies (Steinbeck et al., 1971; Balbontin 
& Ferrario, 1993). The prolonged suppression of testoste-
rone levels beyond the end of treatment may be the direct 
consequence of changes in testicular histology. Certainly, 
a positive correlation has been reported between testos-
terone secretion and the interstitial volume between the 
Leydig cells, and the testicular lymphatic space in rodents 
and swine (Mendis-Handagama et al., 1988). Testostero-
ne-related changes in the testicular germinal epithelium, 
and subsequently in sperm morphometric characteris-
tics, can happen in a relatively short period of time. For 
example, under physiological conditions, changes in the 
germinal epithelium in rams occur rapidly at the end of 
the reproductive season, coinciding with falling testoste-
rone concentrations (Martínez-Fresneda et al., 2019a). In 
rats, treatment with CPA has a mild inhibitory influence 
on spermatogenesis; there is no change in sperm tubule 
diameter, but the size of the accessory glands is strongly 
reduced (Steinbeck et al., 1971). 
The present data for the bucks also suggest CPA 
treatment to have a mild inhibitory effect on spermato-
genesis since sperm concentrations did not fall to values 
close to zero at any time. In contrast, in the rams, the in-
fluence of CPA treatment on spermatogenic activity was 
much greater: in weeks 11-13 of the experimental pe-
riod, strong reductions in sperms counts were evident. 
Figure 2. Changes in semen characteristics for the Spanish Merino rams (mean ± SEM) in the 
control (□) and treatment (■) groups during the experimental period. Asterisks indicate significant 
differences (*p <0.05, ** p <0.01) between groups within weeks. VCL: curvilinear velocity; VSL: 
straight-line velocity.
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Although semen characteristics were affected in both bucks 
and rams, the extent of damage incurred, and the duration 
of the temporary contraception effect achieved, differed 
between the two species. The length of the spermatogenic 
cycle is very similar in both bucks and rams (about 48 
days, França et al., 1999), and thus other causes should 
explain interspecies differences in the response to CPA 
treatment, for example differences in their androgen sen-
sitivity. Indeed it is well known that some species respond 
more strongly to anti-androgen treatment than others 
(Neumann et al., 1976). This higher sensitivity to CPA 
treatment in ovine than caprine species occurred despite 
the similar effect of treatment on testosterone secretion. 
Inter-species variation in the response to testosterone 
administration has been previously reported in a recent 
experiment, showing that frozen-thawed semen characte-
ristics of ram were more sensitive to in vitro supplemen-
tation with testosterone than buck sperm (Martínez-Fres-
neda et al., 2019b). However, while sperm quality was 
affected in both species, spermatogenic activity was not 
entirely reduced in both rams and goats. While CPA in-
duces testosterone levels similar to those seen outside the 
reproductive season, it is well known that in these species 
semen quality falls during this time, but spermatogene-
sis is not prevented (Arrebola et al., 2010; Martí et al., 
2012). Similarly, spermatogenic activity is not entirely 
arrested in more seasonal bovid species such as mouflons 
and ibexes (Coloma et al., 2011), unlike cervid species in 
which spermatogenesis is totally arrested out of reproduc-
tive season (Blottner et al., 1996). Treated males of either 
species were capable to mount and ejaculate before week 
7, despite the arrest of testosterone secretion. Maybe, 
Figure 3. Changes in semen characteristics for the Murciano-granadina bucks (mean 
± SEM) in the control (□) and treatment (■) groups during the experimental period. 
Asterisks indicate significant differences (*p <0.05, ** p <0.01) between groups wi-
thin weeks. VCL: curvilinear velocity; VSL: straight-line velocity.
8 Viviana N. Flores-Gil, Rosario Velázquez, Adolfo Toledano-Díaz  et al.
Spanish Journal of Agricultural Research December 2020 • Volume 18 • Issue 4 • e0407
different stimuli such as the contact with active males 
(control group), the oestrus induced ewe used as a teaser, 
the routine handling during semen collection sessions, 
and other visual and olfactory signals in the collection 
room, stimulated sexual behaviour for mounting (Carrillo 
et al., 2011; Ungerfeld et al., 2019). 
There is a close relationship between the levels of 
testosterone in blood plasma and the dimensions of the 
head of human sperm (Garrett et al., 2005). Some authors 
have reported that during the non-breeding season (cha-
racterized by being an endocrine scenario of low plasma 
testosterone concentrations) ram ejaculates show a reduc-
tion in the size of the sperm head (Martí et al., 2012). 
This is possibly related to changes in the activity of the 
germinal epithelium and Sertoli cells (Martínez-Fresne-
da et al., 2019a). The manchette is a transient microtu-
bular platform in elongating spermatids that play a rele-
vant role on the head shaping (Lehti & Sironen, 2016); a 
certain influence of testosterone levels on the organiza-
tion of manchette might also explain variations in sperm 
head dimension. 
A close relationship exists between androgen con-
centrations and semen characteristics (Smith & Walker, 
2014). In the present work, CPA treatment reduced 
sperm motility and viability, and increased the percen-
tage of sperms showing abnormalities. These negative 
effects are probably explained by the morphological and 
functional changes experienced by the epididymis as a 
result of treatment, which include the degeneration of its 
epithelium and the alteration of its polypeptide profile 
(Roy & Chatterjee, 1979; Kaur et al., 1992). Additiona-
lly, in bucks CPA treatment is reported to have an effect 
on sperm maturation in the epididymis; the morpholo-
gical changes seen during CPA treatment may therefore 
be related to a reduction in the number of mature sperm 
(Panda & Jindal, 1982). In agreement with previous re-
ports (Roy & Chatterjee, 1979; Kaur et al., 1992), CPA 
treatment led - in both species - to a significant increase 
in the percentage of sperms with morphological abnor-
malities, especially of the decapitated and coiled tail 
type. Both could be related to alterations in the matu-
ration process in the epididymis during testosterone de-
privation. CPA treatment also negatively affected sperm 
motility (Kaur et al., 1992), perhaps reflecting the cumu-
lative effects of structural and functional damage incu-
rred during spermatogenesis and maturation. The negati-
ve effects of CPA on the accessory sex glands, including 
the involution of the prostate gland and seminal vesicles 
(Neumann & Kalmus, 1991; Balbontin & Ferrario, 1993) 
must also affect sperm kinetic activity (Elzanaty et al., 
2002). Testosterone in ram seminal plasma fluctuates in 
a manner similar to that seen in blood plasma (Warikoo 
et al., 1986; Casao et al., 2010). In binding to sites on 
the principal piece and midpiece of the tail it seems to 
regulate kinetic activity. Thus, the fall in testosterone in 
the seminal plasma caused by CPA treatment could ne-
gatively affect sperm motility. 
In humans, CPA treatment induces complete azoosper-
mia when combined with testosterone (Meriggiola et al., 
1997). The combination of CPA with testosterone should 
be tested in small ruminants to evaluate its effect on the 
suppression of spermatogenesis. CPA has been used in 
animals for manipulation of cycle antler in cervids (e.g. 
fallow deer (Bartoš et al., 2000); red deer (Jaczewski et 
al., 2004); pudu (Bubenik et al., 2002), but not as a poten-
tial contraceptive drug.  
Week 0 Week 8 Week 13
Control CPA Control CPA Control CPA
Ram sperm
Length (µm) 8.95 ± 0.26 9.14 ± 0.02A 9.07 ± 0.35 8.32 ± 1.17B 9.29 ± 0.13 8.61 ± 0.44B
Width (µm) 4.76 ± 0.16 4.92 ± 0.08 4.78 ± 0.12 4.52 ± 0.47 4.93 ± 0.03 4.74 ± 0.20
Area (µm2) 35.12 ± 1.74 37.04 ± 0.66A 35.77 ± 1.92 31.30 ± 7.50B 37.71 ± 0.36 33.76 ± 2.97B
Perimeter (µm) 23.62 ± 0.61 24.22 ± 0.20A 23.87 ± 0.85 22.08 ± 2.81B 24.45 ± 0.23 22.89 ± 1.06B
Buck sperm
Length (µm) 8.61 ± 0.27 8.57 ± 0.21 8.94 ± 0.24 8.78 ± 0.25 8.90 ± 0.09 8.58 ± 0.18
Width (µm) 3.99 ± 0.23 3.94 ± 0.08 4.17 ± 0.14 4.19 ± 0.11 3.96 ± 0.23 4.06 ± 0.06
Area (µm2) 28.59 ± 2.36 27.96 ± 0.13 30.80 ± 1.04 30.43 ± 1.57 29.18 ± 1.36 28.87 ± 0.95
Perimeter (µm) 21.79 ± 0.85 21.65 ± 0.32 22.79 ± 0.45 22.48 ± 0.57 22.31 ± 0.13 21.90 ± 0.35
Table 1. Mean length, width, area and perimeter of ram and bucks sperm heads (mean ± SD).
The capital letters (A-B) indicate significant differences (p < 0.05) within each group throughout the experimental period. 
CPA = Cyproterone acetate
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Anti-GnRH vaccines have also been used as contra-
ceptive treatments in ruminants. In pygmy goat bucks, 
such treatment leads to reductions in testosterone con-
centrations to basal levels, reductions in the size of the 
accessory sex glands, a reduced sperm concentration, and 
increases in the proportion of sperms with morphological 
abnormalities, all for about 6 months. As with the pre-
sent CPA-treatment, such immunization does not fully 
prevent spermatogenesis (Martínez-Nevado et al., 2016). 
However, CPA effects seem rapidly reversible and there-
fore CPA is more useful as a shorter-term contraceptive 
treatment. Other contraceptive treatments for ruminants 
are based on the use of GnRH agonists and subcutaneous 
implants of deslorelin (which inhibits the reproductive 
axis for some 17 months), but again, neither cause azoos-
permia (Giriboni et al., 2019). Contraceptive methods de-
veloped so far in small ruminants are not totally reliable 
to prevent pregnancies. However, taking into account that 
libido is positively related to testosterone concentrations 
and considering the large decrease in sperm production 
and quality, mainly in rams, the fertility would be greatly 
reduced after CPA treatment. 
In livestock production systems, short term contracep-
tive treatments with CPA can be a useful tool to allow 
keeping infertile males together with females to facilitate 
the management in extensive farming, or when seasonal 
movement of livestock (transhumance) avoiding mating 
is required. In addition, it may be useful to reduce aggres-
sive behaviour without altering group’s social structure 
(Rosenfield et al., 2019). 
In conclusion, treatment with CPA affected testostero-
ne secretion, semen characteristics and sperm morphome-
try in rams and bucks, and thus it might be used as a short 
term contraceptive protocol in small ruminants. Although 
testosterone fell to basal levels, which should induce a 
lack of libido and promote semen characteristics similar 
to that observed outside of the reproductive season, sper-
matogenesis was not fully suppressed in either species, 
though it was much more strongly inhibited in the rams. 
Alternative patterns of CPA administration to improve a 
short term protocol for a reversible temporal contracep-
tion in small ruminants should be explored.
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